Massive stroke pathophysiology
Pro Research Analysisby 
Searched over 200M research papers
Pathophysiology of Massive Ischemic Stroke: Key Mechanisms
Massive ischemic stroke occurs when a large area of the brain is deprived of blood flow, leading to severe neurological deficits and high rates of disability and death. The pathophysiology involves a complex interplay of vascular, cellular, and systemic processes.
Vascular Occlusion and Initial Injury
Massive strokes are often associated with large artery occlusions, frequently due to cardio-embolic events or atherosclerosis, which abruptly block blood supply to extensive brain regions. This leads to rapid energy failure, loss of ion gradients, and neuronal dysfunction in the affected area Bill2012Maida2024Kaiser2020.
Ischemic Cascade: Cellular and Molecular Events
The deprivation of oxygen and glucose triggers a cascade of damaging events:
- Excitotoxicity: Excessive release of excitatory neurotransmitters (like glutamate) overstimulates neurons, causing calcium overload and cell death Xing2012Khoshnam2017Maida2024+1 MORE.
- Oxidative and Nitrative Stress: The production of reactive oxygen and nitrogen species damages cellular components, furthering neuronal injury Khoshnam2017Maida2024Qin2022.
- Inflammation: Activation of microglia and infiltration of immune cells lead to the release of inflammatory mediators, worsening tissue damage Xing2012Khoshnam2017Maida2024+2 MORE.
- Apoptosis: Programmed cell death pathways are activated, contributing to the loss of neurons and glial cells Khoshnam2017Maida2024Qin2022.
White Matter and Systemic Involvement
White matter is particularly vulnerable in massive strokes, with demyelination and axonal injury contributing to long-term deficits Xing2012Kaiser2020. Beyond the brain, acute ischemic stroke can trigger systemic responses, including immunodepression and dysfunction in organs such as the lungs, heart, and kidneys, which can increase morbidity and mortality .
Role of Inflammation and Blood Biomarkers
Persistent inflammation, as indicated by elevated neutrophil-to-lymphocyte ratios and high white cell counts, is linked to worse short-term outcomes, higher mortality, and increased risk of infections like pneumonia in massive stroke patients Bill2012Hou2021. Elevated blood glucose at admission is also associated with poorer prognosis Bill2012Hou2021.
Genetic and Molecular Regulators
Non-coding RNAs, especially microRNAs and long non-coding RNAs, play important roles in regulating the response to ischemia, influencing processes like angiogenesis, neuroprotection, and recovery. These molecules are being explored as potential therapeutic and diagnostic tools .
Imaging and Predictors of Outcome
Early neuroimaging often reveals extensive ischemic changes and arterial occlusions in massive stroke. Factors such as lower age, prior cerebrovascular events, hypolipemic pretreatment, lower acute temperature, lower glucose levels, and early recanalization are associated with better outcomes, even in severe cases .
Conclusion
Massive ischemic stroke is characterized by large vessel occlusion and a rapid, multifaceted pathophysiological cascade involving excitotoxicity, oxidative stress, inflammation, and apoptosis. Systemic complications and persistent inflammation further worsen outcomes. Understanding these mechanisms is crucial for developing effective therapies and improving prognosis in patients with massive stroke Bill2012Xing2012Khoshnam2017+6 MORE.
Sources and full results
Most relevant research papers on this topic